Marubi(SH:603983) Xin Lang Cai Jing·2025-10-15 02:20Core Insights - Marubi Biotech's stock price increased by 2.02% on October 15, reaching 38.36 CNY per share, with a total market capitalization of 15.382 billion CNY [1] - The company has seen a year-to-date stock price increase of 20.78%, but has experienced declines of 3.62% over the past five trading days, 3.91% over the past twenty days, and 5.26% over the past sixty days [1] - Marubi Biotech's main business includes the research, design, production, sales, and service of various skincare products, with revenue composition as follows: skincare 39.20%, beauty and others 29.30%, eye care 23.75%, cleansing 7.66%, and others 0.10% [1] Financial Performance - For the first half of 2025, Marubi Biotech achieved revenue of 1.769 billion CNY, representing a year-on-year growth of 30.83%, and a net profit attributable to shareholders of 186 million CNY, up 5.21% year-on-year [2] - The company has distributed a total of 983 million CNY in dividends since its A-share listing, with 610 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 36.85% to 17,400, while the average number of tradable shares per person decreased by 26.93% to 23,084 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 4.85 million shares, an increase of 1.485 million shares compared to the previous period [3]